Literature DB >> 1754909

Pulmonary Aspergillus chest wall involvement in chronic granulomatous disease: CT and MRI findings.

A Kawashima1, J E Kuhlman, E K Fishman, C M Tempany, D Magid, H M Lederman, J A Winkelstein, E A Zerhouni.   

Abstract

Pulmonary Aspergillus infection in patients with chronic granulomatous disease tends to involve the chest wall and consequently carries a high mortality rate. We report the findings of computed tomography (CT) and magnetic resonance imaging (MRI) in three such cases. One patient underwent both CT and MRI, one, CT only, and one, MRI only. In all three, both CT and MRI demonstrated pulmonary consolidations with direct extension to the adjacent chest wall. In both patients who were examined by CT, scans revealed permeative osteolytic changes of adjacent rib or spine compatible with osteomyelitis. In both patients who were examined by MRI, adjacent chest wall involvement was depicted on T1-weighted images and showed increased signal intensity on T2-weighted images. In one of these patients, the chest wall lesion was well defined on T2-weighted images, an appearance compatible with abscess. Epidural extension was demonstrated on MRI in the other patient, who later developed paraparesis. We suggest that CT and MRI have a complementary role in evaluating chest wall invasion by pulmonary Aspergillus infection in chronic granulomatous disease.

Entities:  

Mesh:

Year:  1991        PMID: 1754909     DOI: 10.1007/bf00194242

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  17 in total

1.  Incidence, severity, and prevention of infections in chronic granulomatous disease.

Authors:  R Mouy; A Fischer; E Vilmer; R Seger; C Griscelli
Journal:  J Pediatr       Date:  1989-04       Impact factor: 4.406

2.  Thoracic wall invasion secondary to pulmonary aspergillosis: a complication of chronic granulomatous disease of childhood.

Authors:  A R Altman
Journal:  AJR Am J Roentgenol       Date:  1977-07       Impact factor: 3.959

3.  Chest wall invasion by aspergillus in chronic granulomatous disease of childhood.

Authors:  G Gaisie; A Bowen; F L Quattromani; K S Oh
Journal:  Pediatr Radiol       Date:  1981

4.  Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi.

Authors:  M S Cohen; R E Isturiz; H L Malech; R K Root; C M Wilfert; L Gutman; R H Buckley
Journal:  Am J Med       Date:  1981-07       Impact factor: 4.965

5.  Aspergillus pneumonia in chronic granulomatous disease: recurrence and long-term outcome.

Authors:  D S Chudwin; D W Wara; M J Cowan; A J Ammann
Journal:  Acta Paediatr Scand       Date:  1982-11

6.  Skeletal involvement in children who have chronic granulomatous disease.

Authors:  P D Sponseller; H L Malech; E F McCarthy; S F Horowitz; G Jaffe; J I Gallin
Journal:  J Bone Joint Surg Am       Date:  1991-01       Impact factor: 5.284

7.  Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.

Authors:  R A Clark; H L Malech; J I Gallin; H Nunoi; B D Volpp; D W Pearson; W M Nauseef; J T Curnutte
Journal:  N Engl J Med       Date:  1989-09-07       Impact factor: 91.245

8.  Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease.

Authors:  J Bernhisel-Broadbent; E E Camargo; H S Jaffe; H M Lederman
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

9.  Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.

Authors:  P E Newburger; R A Ezekowitz
Journal:  Hematol Oncol Clin North Am       Date:  1988-06       Impact factor: 3.722

Review 10.  Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies.

Authors:  A I Tauber; N Borregaard; E Simons; J Wright
Journal:  Medicine (Baltimore)       Date:  1983-09       Impact factor: 1.889

View more
  8 in total

Review 1.  Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Brad Moriyama; Nikolaos V Sipsas; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Roberta Prinapori; Saad J Taj-Aldeen; Barry Brause; Olivier Lortholary; Thomas J Walsh
Journal:  J Infect       Date:  2013-12-27       Impact factor: 6.072

2.  Spontaneous cord transection due to invasive aspergillus spondylitis in an immunocompetent child.

Authors:  K Karthik; Ajoy Prasad Shetty; S Rajasekaran
Journal:  Eur Spine J       Date:  2010-07-02       Impact factor: 3.134

Review 3.  Imaging Approach to Pulmonary Infections in the Immunocompromised Patient.

Authors:  Shabnam Bhandari Grover; Hemal Grover; Neha Antil; Sayantan Patra; Manas Kamal Sen; Deepthi Nair
Journal:  Indian J Radiol Imaging       Date:  2022-05-27

4.  The radiological spectrum of invasive aspergillosis in children: a 10-year review.

Authors:  Karen E Thomas; Catherine M Owens; Paul A Veys; Vas Novelli; Vera Costoli
Journal:  Pediatr Radiol       Date:  2003-05-09

5.  Spinal epidural aspergillosis in a patient with HIV resulting from long-standing (3 years) lung infection.

Authors:  R D Murtagh; M J D Post; J Bruce; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

6.  Chronic granulomatous disease: a review of the infectious and inflammatory complications.

Authors:  Eunkyung Song; Gayatri Bala Jaishankar; Hana Saleh; Warit Jithpratuck; Ryan Sahni; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-05-31

7.  Imaging findings of pulmonary manifestations of chronic granulomatous disease in a large single center from Shanghai, China (1999-2018).

Authors:  Qiong Yao; Qin-Hua Zhou; Quan-Li Shen; Zhong-Wei Qiao; Xiao-Chuan Wang; Xi-Hong Hu
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

Review 8.  Considerations in the Diagnosis of Chronic Granulomatous Disease.

Authors:  Joyce E Yu; Antoine E Azar; Hey J Chong; Artemio M Jongco; Benjamin T Prince
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.